Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
They also discuss:
- Why Luis and his co-founder, two machine learning engineers, decided to start a bio startup.
- How Immunai uses single-cell genomics to map out the immune system.
- The trajectory of Immunai’s experiments from the lab to the patient.
@Azeem
@exponentialview
@Immunaitech
Further resources:
Scaling Synthetic Biology (with Gingko’s Reshma Shetty), Exponential View Podcast, 2022
The Future of Healthcare: Personalization and AI (with ZOE’s Jonathan Wolf), Exponential View Podcast, 2022
A transcript of this episode will be available by April 13, 2022.
